Sector dividends Marker Therapeutics, Inc.
Equities
MRKR
US57055L2060
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.040 USD | -6.85% |
|
+12.09% | +36.91% |
| 11-14 | Marker Therapeutics Q3 net loss narrows to $2 mln | RE |
| 11-13 | Marker Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | -2.32x | - | - | - | - | 36.51M | |
| 0.88% | 1% | 38.75x | 3.99x | 5.63x | 18.83x | 27.64x | 49.32B | |
| -.--% | -.--% | 33.99x | 6.47x | 3.36x | 14.4x | 23.35x | 41.11B | |
| -.--% | -.--% | 104.52x | 9.45x | 6.7x | 67.33x | 97.79x | 37.81B | |
| 0.36% | 0.37% | 53.86x | 2.58x | 11.05x | 30.72x | 39.67x | 30.48B | |
| -.--% | -.--% | -21.04x | 14.32x | 6104.01x | -19.94x | -19.7x | 22.72B | |
| -.--% | -.--% | 41.92x | 41.86x | 6.8x | 30.91x | 32.39x | 17.48B | |
| 0.91% | 0.97% | 26.9x | 2.39x | 2.18x | 9.77x | 15.11x | 14.47B | |
| -.--% | -.--% | 27.44x | 1.51x | 2.12x | 10.85x | 12.07x | 14.12B | |
| -.--% | -.--% | -53.33x | 1424.96x | 15.54x | -114.45x | -86.12x | 13.3B | |
| -.--% | -.--% | -35.05x | 46.73x | 13.29x | -37.9x | -33.23x | 12.87B | |
| -.--% | -.--% | -43.95x | 22.72x | 9.66x | 24586.8x | -200.04x | 11.62B | |
| 0.36% | 0.41% | 28.03x | 3.02x | 5.65x | 15.29x | 19.08x | 11.47B | |
| 0.45% | 0.45% | 55.76x | 5.11x | 9.05x | 25.64x | 27.91x | 11.12B | |
| -.--% | -.--% | 54.08x | 3.17x | 3.27x | 13.55x | 16.49x | 11.16B | |
| Average | 0.21% | 0.23% | 20.64x | 113.45x | 442.74x | 1,760.84x | -1.97x | 19.94B | |
| Weighted average by Cap. | 0.26% | 0.28% | 32.79x | 73.42x | 470.07x | 968.80x | 15.22x |
- Stock Market
- Equities
- MRKR Stock
- Sector Marker Therapeutics, Inc.
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition